Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.32KPrice to Sales
VS
Market
Sector
Industry
History
$ 3.26Close
$ 1.43 - $ 5.13 52-Week Range
Ticker Information
Ticker
TCRTCompany Name
ALAUNOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALAUNOS THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TCRT - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 5.27M | 1.32K | $ 4K |
| 3/31/2025 | $ 4.62M | 577.93 | $ 8K |
| 12/31/2024 | $ 2.35M | 235.38 | $ 10K |
| 9/30/2024 | $ 3.74M | 748.75 | $ 5K |
| 6/30/2024 | $ 3.88M | 775.01 | $ 5K |
| 3/31/2024 | $ 19.05M | 3.81K | $ 5K |
| 12/31/2023 | $ 28.02M | 5.6K | $ 5K |
| 9/30/2023 | $ 17.88M | 1.19K | $ 15K |
| 6/30/2023 | $ 94.71M | 32.37 | $ 2.93M |
| 3/31/2023 | $ 149.16M | 51.05 | $ 2.92M |
Key Performance Insights, Last 5 Years
- ALAUNOS THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, ALAUNOS THERAPEUTICS INC's average P/S has been 1.07K.
- The median P/S for ALAUNOS THERAPEUTICS INC during this period was 663.34
- ALAUNOS THERAPEUTICS INC reached its highest P/S over the past 5 years at 5.6K.
- The lowest P/S recorded by ALAUNOS THERAPEUTICS INC in the same timeframe 32.37
ALAUNOS THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ALAUNOS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 518.58M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] TCRT - Price to Sales, Last 5 years
32.37
Minimum
Jun 30, 2023
5.6K
Maximum
Dec 31, 2023
1.07K
Average
663.34
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |